Texas demanda a los fabricantes de Tylenol por supuesto encubrimiento de riesgos de autismonews2025-10-28T16:54:47+00:00October 28th, 2025|The New York Times|
Texas Sues Tylenol Makers, Claiming They Hid Autism Risksnews2025-10-28T12:24:44+00:00October 28th, 2025|The New York Times|
Un decano de Harvard cobró 150.000 dólares como perito en las demandas contra Tylenolnews2025-09-24T18:51:33+00:00September 24th, 2025|The New York Times|
F.D.A.’s Approval of a Drug for Autism Upends Review Processnews2025-09-23T23:09:46+00:00September 23rd, 2025|The New York Times|
Harvard Dean Was Paid $150,000 as an Expert Witness in Tylenol Lawsuitsnews2025-09-23T21:57:24+00:00September 23rd, 2025|The New York Times|
4 Autism Experts React to Trump’s Plannews2025-09-23T18:50:52+00:00September 23rd, 2025|The New York Times|
America’s Vaccine Future Is at a Crossroadsnews2025-09-19T20:33:33+00:00September 19th, 2025|The New York Times|
R.F.K. Jr. Said Trump Promised Him Control of Public Health Agencies. The Campaign Called That Premature.news2024-10-30T18:32:40+00:00October 30th, 2024|The New York Times|
EarliPoint Evaluation System for ASD Diagnosis: Interview with Tom Ressemann, CEO of EarliTec Dxnews2023-08-08T21:36:09+00:00August 8th, 2023|Medgadget|